nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunisolide—Growth retardation—Dactinomycin—germ cell cancer	0.0439	0.0483	CcSEcCtD
Flunisolide—Growth retardation—Ifosfamide—germ cell cancer	0.0403	0.0442	CcSEcCtD
Flunisolide—Ocular discomfort—Methotrexate—germ cell cancer	0.019	0.0209	CcSEcCtD
Flunisolide—Pleurisy—Methotrexate—germ cell cancer	0.0177	0.0195	CcSEcCtD
Flunisolide—Dexamethasone—NR0B1—germ cell cancer	0.0176	1	CrCbGaD
Flunisolide—Numbness—Vinblastine—germ cell cancer	0.0153	0.0168	CcSEcCtD
Flunisolide—Sensory loss—Vinblastine—germ cell cancer	0.0146	0.0161	CcSEcCtD
Flunisolide—Wheezing—Bleomycin—germ cell cancer	0.0104	0.0114	CcSEcCtD
Flunisolide—Rhinorrhoea—Cisplatin—germ cell cancer	0.00973	0.0107	CcSEcCtD
Flunisolide—Ageusia—Cisplatin—germ cell cancer	0.00973	0.0107	CcSEcCtD
Flunisolide—Numbness—Etoposide—germ cell cancer	0.00871	0.00957	CcSEcCtD
Flunisolide—Injury—Bleomycin—germ cell cancer	0.00845	0.00928	CcSEcCtD
Flunisolide—Sensory loss—Etoposide—germ cell cancer	0.00833	0.00916	CcSEcCtD
Flunisolide—Chest discomfort—Etoposide—germ cell cancer	0.00816	0.00897	CcSEcCtD
Flunisolide—Wheezing—Cisplatin—germ cell cancer	0.00765	0.00841	CcSEcCtD
Flunisolide—NR3C1—urine—germ cell cancer	0.00751	0.104	CbGeAlD
Flunisolide—Candida infection—Etoposide—germ cell cancer	0.00689	0.00757	CcSEcCtD
Flunisolide—Bronchospasm—Bleomycin—germ cell cancer	0.0066	0.00725	CcSEcCtD
Flunisolide—Hypoaesthesia—Vinblastine—germ cell cancer	0.00633	0.00695	CcSEcCtD
Flunisolide—Pharyngitis—Vinblastine—germ cell cancer	0.00631	0.00694	CcSEcCtD
Flunisolide—Nasal congestion—Cisplatin—germ cell cancer	0.00628	0.0069	CcSEcCtD
Flunisolide—Pneumonia—Bleomycin—germ cell cancer	0.00602	0.00661	CcSEcCtD
Flunisolide—Stomatitis—Bleomycin—germ cell cancer	0.00583	0.00641	CcSEcCtD
Flunisolide—CYP3A4—urine—germ cell cancer	0.00568	0.0785	CbGeAlD
Flunisolide—Bronchospasm—Ifosfamide—germ cell cancer	0.00564	0.0062	CcSEcCtD
Flunisolide—Pneumonia—Dactinomycin—germ cell cancer	0.00561	0.00617	CcSEcCtD
Flunisolide—Irritability—Cisplatin—germ cell cancer	0.00546	0.006	CcSEcCtD
Flunisolide—Stomatitis—Dactinomycin—germ cell cancer	0.00544	0.00598	CcSEcCtD
Flunisolide—Hypoaesthesia—Bleomycin—germ cell cancer	0.00534	0.00587	CcSEcCtD
Flunisolide—Pneumonia—Ifosfamide—germ cell cancer	0.00514	0.00565	CcSEcCtD
Flunisolide—Ill-defined disorder—Vinblastine—germ cell cancer	0.00514	0.00564	CcSEcCtD
Flunisolide—Nasopharyngitis—Cisplatin—germ cell cancer	0.00512	0.00562	CcSEcCtD
Flunisolide—Malaise—Vinblastine—germ cell cancer	0.00499	0.00549	CcSEcCtD
Flunisolide—Stomatitis—Ifosfamide—germ cell cancer	0.00498	0.00548	CcSEcCtD
Flunisolide—Vertigo—Vinblastine—germ cell cancer	0.00497	0.00547	CcSEcCtD
Flunisolide—Pharyngitis—Dactinomycin—germ cell cancer	0.00497	0.00546	CcSEcCtD
Flunisolide—Conjunctivitis—Ifosfamide—germ cell cancer	0.00497	0.00546	CcSEcCtD
Flunisolide—Chills—Bleomycin—germ cell cancer	0.00482	0.0053	CcSEcCtD
Flunisolide—Hypertension—Vinblastine—germ cell cancer	0.00478	0.00525	CcSEcCtD
Flunisolide—Abdominal discomfort—Cisplatin—germ cell cancer	0.00474	0.00521	CcSEcCtD
Flunisolide—Erythema multiforme—Dactinomycin—germ cell cancer	0.00474	0.0052	CcSEcCtD
Flunisolide—Glossitis—Methotrexate—germ cell cancer	0.00469	0.00516	CcSEcCtD
Flunisolide—Discomfort—Vinblastine—germ cell cancer	0.00466	0.00512	CcSEcCtD
Flunisolide—Chills—Dactinomycin—germ cell cancer	0.00449	0.00494	CcSEcCtD
Flunisolide—Bronchospasm—Etoposide—germ cell cancer	0.00446	0.0049	CcSEcCtD
Flunisolide—Erythema multiforme—Ifosfamide—germ cell cancer	0.00434	0.00477	CcSEcCtD
Flunisolide—Ill-defined disorder—Bleomycin—germ cell cancer	0.00434	0.00477	CcSEcCtD
Flunisolide—Vaginal inflammation—Methotrexate—germ cell cancer	0.00432	0.00475	CcSEcCtD
Flunisolide—Stomatitis—Cisplatin—germ cell cancer	0.0043	0.00472	CcSEcCtD
Flunisolide—Conjunctivitis—Cisplatin—germ cell cancer	0.00429	0.00471	CcSEcCtD
Flunisolide—Malaise—Bleomycin—germ cell cancer	0.00422	0.00463	CcSEcCtD
Flunisolide—Chills—Ifosfamide—germ cell cancer	0.00412	0.00453	CcSEcCtD
Flunisolide—Vaginal infection—Methotrexate—germ cell cancer	0.00408	0.00449	CcSEcCtD
Flunisolide—Cough—Bleomycin—germ cell cancer	0.00408	0.00448	CcSEcCtD
Flunisolide—Pneumonia—Etoposide—germ cell cancer	0.00406	0.00446	CcSEcCtD
Flunisolide—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00405	0.00445	CcSEcCtD
Flunisolide—Malnutrition—Ifosfamide—germ cell cancer	0.004	0.00439	CcSEcCtD
Flunisolide—Chest pain—Bleomycin—germ cell cancer	0.00398	0.00437	CcSEcCtD
Flunisolide—Myalgia—Bleomycin—germ cell cancer	0.00398	0.00437	CcSEcCtD
Flunisolide—Stomatitis—Etoposide—germ cell cancer	0.00394	0.00433	CcSEcCtD
Flunisolide—Discomfort—Bleomycin—germ cell cancer	0.00393	0.00432	CcSEcCtD
Flunisolide—Malaise—Dactinomycin—germ cell cancer	0.00393	0.00432	CcSEcCtD
Flunisolide—Decreased appetite—Vinblastine—germ cell cancer	0.00393	0.00432	CcSEcCtD
Flunisolide—Constipation—Vinblastine—germ cell cancer	0.00386	0.00425	CcSEcCtD
Flunisolide—Pain—Vinblastine—germ cell cancer	0.00386	0.00425	CcSEcCtD
Flunisolide—Oedema—Bleomycin—germ cell cancer	0.00382	0.00419	CcSEcCtD
Flunisolide—Infection—Bleomycin—germ cell cancer	0.00379	0.00417	CcSEcCtD
Flunisolide—Vision blurred—Ifosfamide—germ cell cancer	0.00377	0.00414	CcSEcCtD
Flunisolide—Feeling abnormal—Vinblastine—germ cell cancer	0.00372	0.00409	CcSEcCtD
Flunisolide—Myalgia—Dactinomycin—germ cell cancer	0.00371	0.00408	CcSEcCtD
Flunisolide—Ill-defined disorder—Ifosfamide—germ cell cancer	0.00371	0.00407	CcSEcCtD
Flunisolide—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00369	0.00406	CcSEcCtD
Flunisolide—Lymphadenopathy—Methotrexate—germ cell cancer	0.00368	0.00404	CcSEcCtD
Flunisolide—SERPINA6—pituitary gland—germ cell cancer	0.00367	0.0507	CbGeAlD
Flunisolide—Agitation—Ifosfamide—germ cell cancer	0.00367	0.00404	CcSEcCtD
Flunisolide—Discomfort—Dactinomycin—germ cell cancer	0.00367	0.00403	CcSEcCtD
Flunisolide—Hypoaesthesia—Etoposide—germ cell cancer	0.00361	0.00396	CcSEcCtD
Flunisolide—Malaise—Ifosfamide—germ cell cancer	0.0036	0.00396	CcSEcCtD
Flunisolide—Vertigo—Ifosfamide—germ cell cancer	0.00359	0.00395	CcSEcCtD
Flunisolide—Abdominal pain—Vinblastine—germ cell cancer	0.00357	0.00393	CcSEcCtD
Flunisolide—Oedema—Dactinomycin—germ cell cancer	0.00356	0.00391	CcSEcCtD
Flunisolide—Infection—Dactinomycin—germ cell cancer	0.00354	0.00389	CcSEcCtD
Flunisolide—Palpitations—Ifosfamide—germ cell cancer	0.00353	0.00388	CcSEcCtD
Flunisolide—Cough—Ifosfamide—germ cell cancer	0.00349	0.00383	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00348	0.00382	CcSEcCtD
Flunisolide—Hypertension—Ifosfamide—germ cell cancer	0.00345	0.00379	CcSEcCtD
Flunisolide—Malnutrition—Cisplatin—germ cell cancer	0.00345	0.00379	CcSEcCtD
Flunisolide—Erythema multiforme—Etoposide—germ cell cancer	0.00343	0.00377	CcSEcCtD
Flunisolide—Dyspnoea—Bleomycin—germ cell cancer	0.0034	0.00374	CcSEcCtD
Flunisolide—Myalgia—Ifosfamide—germ cell cancer	0.0034	0.00374	CcSEcCtD
Flunisolide—Chest pain—Ifosfamide—germ cell cancer	0.0034	0.00374	CcSEcCtD
Flunisolide—Discomfort—Ifosfamide—germ cell cancer	0.00336	0.00369	CcSEcCtD
Flunisolide—Hypersensitivity—Vinblastine—germ cell cancer	0.00333	0.00366	CcSEcCtD
Flunisolide—Decreased appetite—Bleomycin—germ cell cancer	0.00332	0.00365	CcSEcCtD
Flunisolide—SERPINA6—adrenal gland—germ cell cancer	0.00328	0.0453	CbGeAlD
Flunisolide—Pain—Bleomycin—germ cell cancer	0.00326	0.00359	CcSEcCtD
Flunisolide—Oedema—Ifosfamide—germ cell cancer	0.00326	0.00358	CcSEcCtD
Flunisolide—Chills—Etoposide—germ cell cancer	0.00325	0.00357	CcSEcCtD
Flunisolide—Vision blurred—Cisplatin—germ cell cancer	0.00325	0.00357	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00324	0.00356	CcSEcCtD
Flunisolide—Asthenia—Vinblastine—germ cell cancer	0.00324	0.00356	CcSEcCtD
Flunisolide—Infection—Ifosfamide—germ cell cancer	0.00324	0.00356	CcSEcCtD
Flunisolide—Tremor—Cisplatin—germ cell cancer	0.00323	0.00355	CcSEcCtD
Flunisolide—Ill-defined disorder—Cisplatin—germ cell cancer	0.0032	0.00351	CcSEcCtD
Flunisolide—SERPINA6—bone marrow—germ cell cancer	0.00317	0.0439	CbGeAlD
Flunisolide—Hyperhidrosis—Ifosfamide—germ cell cancer	0.00315	0.00346	CcSEcCtD
Flunisolide—Feeling abnormal—Bleomycin—germ cell cancer	0.00314	0.00346	CcSEcCtD
Flunisolide—Malaise—Cisplatin—germ cell cancer	0.00311	0.00341	CcSEcCtD
Flunisolide—Decreased appetite—Dactinomycin—germ cell cancer	0.00309	0.0034	CcSEcCtD
Flunisolide—Diarrhoea—Vinblastine—germ cell cancer	0.00309	0.0034	CcSEcCtD
Flunisolide—Dysgeusia—Etoposide—germ cell cancer	0.00309	0.0034	CcSEcCtD
Flunisolide—Fatigue—Dactinomycin—germ cell cancer	0.00307	0.00337	CcSEcCtD
Flunisolide—Back pain—Etoposide—germ cell cancer	0.00305	0.00335	CcSEcCtD
Flunisolide—Pain—Dactinomycin—germ cell cancer	0.00304	0.00334	CcSEcCtD
Flunisolide—Urticaria—Bleomycin—germ cell cancer	0.00303	0.00333	CcSEcCtD
Flunisolide—Body temperature increased—Bleomycin—germ cell cancer	0.00302	0.00332	CcSEcCtD
Flunisolide—Irritability—Methotrexate—germ cell cancer	0.003	0.00329	CcSEcCtD
Flunisolide—Dizziness—Vinblastine—germ cell cancer	0.00299	0.00328	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.00297	0.00327	CcSEcCtD
Flunisolide—Myalgia—Cisplatin—germ cell cancer	0.00293	0.00322	CcSEcCtD
Flunisolide—Feeling abnormal—Dactinomycin—germ cell cancer	0.00293	0.00322	CcSEcCtD
Flunisolide—Ill-defined disorder—Etoposide—germ cell cancer	0.00293	0.00322	CcSEcCtD
Flunisolide—Anxiety—Cisplatin—germ cell cancer	0.00292	0.00321	CcSEcCtD
Flunisolide—NR3C1—neck—germ cell cancer	0.00291	0.0403	CbGeAlD
Flunisolide—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00291	0.0032	CcSEcCtD
Flunisolide—Dyspnoea—Ifosfamide—germ cell cancer	0.00291	0.0032	CcSEcCtD
Flunisolide—Discomfort—Cisplatin—germ cell cancer	0.0029	0.00318	CcSEcCtD
Flunisolide—Vomiting—Vinblastine—germ cell cancer	0.00287	0.00316	CcSEcCtD
Flunisolide—Malaise—Etoposide—germ cell cancer	0.00285	0.00313	CcSEcCtD
Flunisolide—SERPINA6—endocrine gland—germ cell cancer	0.00285	0.0393	CbGeAlD
Flunisolide—Vertigo—Etoposide—germ cell cancer	0.00284	0.00312	CcSEcCtD
Flunisolide—Decreased appetite—Ifosfamide—germ cell cancer	0.00284	0.00312	CcSEcCtD
Flunisolide—Headache—Vinblastine—germ cell cancer	0.00283	0.00311	CcSEcCtD
Flunisolide—Abdominal pain—Dactinomycin—germ cell cancer	0.00281	0.00309	CcSEcCtD
Flunisolide—Body temperature increased—Dactinomycin—germ cell cancer	0.00281	0.00309	CcSEcCtD
Flunisolide—Fatigue—Ifosfamide—germ cell cancer	0.00281	0.00309	CcSEcCtD
Flunisolide—Oedema—Cisplatin—germ cell cancer	0.00281	0.00309	CcSEcCtD
Flunisolide—Hypersensitivity—Bleomycin—germ cell cancer	0.00281	0.00309	CcSEcCtD
Flunisolide—SERPINA6—head—germ cell cancer	0.00281	0.0388	CbGeAlD
Flunisolide—Infection—Cisplatin—germ cell cancer	0.00279	0.00307	CcSEcCtD
Flunisolide—Pain—Ifosfamide—germ cell cancer	0.00279	0.00306	CcSEcCtD
Flunisolide—Constipation—Ifosfamide—germ cell cancer	0.00279	0.00306	CcSEcCtD
Flunisolide—Loss of consciousness—Etoposide—germ cell cancer	0.00277	0.00305	CcSEcCtD
Flunisolide—Cough—Etoposide—germ cell cancer	0.00275	0.00303	CcSEcCtD
Flunisolide—Tachycardia—Cisplatin—germ cell cancer	0.00274	0.00302	CcSEcCtD
Flunisolide—Asthenia—Bleomycin—germ cell cancer	0.00274	0.00301	CcSEcCtD
Flunisolide—Hypertension—Etoposide—germ cell cancer	0.00272	0.00299	CcSEcCtD
Flunisolide—Hyperhidrosis—Cisplatin—germ cell cancer	0.00272	0.00299	CcSEcCtD
Flunisolide—Pruritus—Bleomycin—germ cell cancer	0.0027	0.00297	CcSEcCtD
Flunisolide—Feeling abnormal—Ifosfamide—germ cell cancer	0.00269	0.00295	CcSEcCtD
Flunisolide—Chest pain—Etoposide—germ cell cancer	0.00269	0.00295	CcSEcCtD
Flunisolide—Nausea—Vinblastine—germ cell cancer	0.00268	0.00295	CcSEcCtD
Flunisolide—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00267	0.00293	CcSEcCtD
Flunisolide—Discomfort—Etoposide—germ cell cancer	0.00265	0.00292	CcSEcCtD
Flunisolide—Hypersensitivity—Dactinomycin—germ cell cancer	0.00262	0.00288	CcSEcCtD
Flunisolide—Abdominal discomfort—Methotrexate—germ cell cancer	0.0026	0.00286	CcSEcCtD
Flunisolide—Urticaria—Ifosfamide—germ cell cancer	0.00259	0.00285	CcSEcCtD
Flunisolide—Body temperature increased—Ifosfamide—germ cell cancer	0.00258	0.00283	CcSEcCtD
Flunisolide—Abdominal pain—Ifosfamide—germ cell cancer	0.00258	0.00283	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00256	0.00281	CcSEcCtD
Flunisolide—Infection—Etoposide—germ cell cancer	0.00256	0.00281	CcSEcCtD
Flunisolide—Asthenia—Dactinomycin—germ cell cancer	0.00255	0.00281	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.00252	0.00277	CcSEcCtD
Flunisolide—NR3C1—trigeminal ganglion—germ cell cancer	0.00252	0.0348	CbGeAlD
Flunisolide—Tachycardia—Etoposide—germ cell cancer	0.00251	0.00276	CcSEcCtD
Flunisolide—Dyspnoea—Cisplatin—germ cell cancer	0.00251	0.00275	CcSEcCtD
Flunisolide—SERPINA6—cerebellum—germ cell cancer	0.00251	0.0346	CbGeAlD
Flunisolide—Hyperhidrosis—Etoposide—germ cell cancer	0.00249	0.00274	CcSEcCtD
Flunisolide—Decreased appetite—Cisplatin—germ cell cancer	0.00244	0.00269	CcSEcCtD
Flunisolide—Diarrhoea—Dactinomycin—germ cell cancer	0.00244	0.00268	CcSEcCtD
Flunisolide—Pneumonia—Methotrexate—germ cell cancer	0.00243	0.00267	CcSEcCtD
Flunisolide—NR3C1—embryo—germ cell cancer	0.00243	0.0336	CbGeAlD
Flunisolide—Vomiting—Bleomycin—germ cell cancer	0.00243	0.00267	CcSEcCtD
Flunisolide—Rash—Bleomycin—germ cell cancer	0.00241	0.00264	CcSEcCtD
Flunisolide—Pain—Cisplatin—germ cell cancer	0.0024	0.00264	CcSEcCtD
Flunisolide—Dermatitis—Bleomycin—germ cell cancer	0.0024	0.00264	CcSEcCtD
Flunisolide—Hypersensitivity—Ifosfamide—germ cell cancer	0.0024	0.00264	CcSEcCtD
Flunisolide—Stomatitis—Methotrexate—germ cell cancer	0.00236	0.00259	CcSEcCtD
Flunisolide—Conjunctivitis—Methotrexate—germ cell cancer	0.00235	0.00258	CcSEcCtD
Flunisolide—Asthenia—Ifosfamide—germ cell cancer	0.00234	0.00257	CcSEcCtD
Flunisolide—Sweating—Methotrexate—germ cell cancer	0.00232	0.00255	CcSEcCtD
Flunisolide—Feeling abnormal—Cisplatin—germ cell cancer	0.00232	0.00255	CcSEcCtD
Flunisolide—Pruritus—Ifosfamide—germ cell cancer	0.00231	0.00254	CcSEcCtD
Flunisolide—Dyspnoea—Etoposide—germ cell cancer	0.0023	0.00252	CcSEcCtD
Flunisolide—Epistaxis—Methotrexate—germ cell cancer	0.00228	0.00251	CcSEcCtD
Flunisolide—Nausea—Bleomycin—germ cell cancer	0.00227	0.00249	CcSEcCtD
Flunisolide—Vomiting—Dactinomycin—germ cell cancer	0.00226	0.00249	CcSEcCtD
Flunisolide—Rash—Dactinomycin—germ cell cancer	0.00224	0.00247	CcSEcCtD
Flunisolide—Decreased appetite—Etoposide—germ cell cancer	0.00224	0.00246	CcSEcCtD
Flunisolide—Diarrhoea—Ifosfamide—germ cell cancer	0.00223	0.00245	CcSEcCtD
Flunisolide—NR3C1—brainstem—germ cell cancer	0.00223	0.0308	CbGeAlD
Flunisolide—Body temperature increased—Cisplatin—germ cell cancer	0.00222	0.00244	CcSEcCtD
Flunisolide—Fatigue—Etoposide—germ cell cancer	0.00222	0.00244	CcSEcCtD
Flunisolide—Constipation—Etoposide—germ cell cancer	0.0022	0.00242	CcSEcCtD
Flunisolide—Pain—Etoposide—germ cell cancer	0.0022	0.00242	CcSEcCtD
Flunisolide—NR3C1—eye—germ cell cancer	0.00217	0.0299	CbGeAlD
Flunisolide—Dizziness—Ifosfamide—germ cell cancer	0.00216	0.00237	CcSEcCtD
Flunisolide—Pharyngitis—Methotrexate—germ cell cancer	0.00216	0.00237	CcSEcCtD
Flunisolide—Feeling abnormal—Etoposide—germ cell cancer	0.00212	0.00233	CcSEcCtD
Flunisolide—Nausea—Dactinomycin—germ cell cancer	0.00211	0.00232	CcSEcCtD
Flunisolide—Gastrointestinal pain—Etoposide—germ cell cancer	0.00211	0.00231	CcSEcCtD
Flunisolide—Vomiting—Ifosfamide—germ cell cancer	0.00207	0.00228	CcSEcCtD
Flunisolide—Hypersensitivity—Cisplatin—germ cell cancer	0.00207	0.00228	CcSEcCtD
Flunisolide—Rash—Ifosfamide—germ cell cancer	0.00206	0.00226	CcSEcCtD
Flunisolide—Dermatitis—Ifosfamide—germ cell cancer	0.00205	0.00226	CcSEcCtD
Flunisolide—Erythema multiforme—Methotrexate—germ cell cancer	0.00205	0.00226	CcSEcCtD
Flunisolide—Urticaria—Etoposide—germ cell cancer	0.00205	0.00225	CcSEcCtD
Flunisolide—Abdominal pain—Etoposide—germ cell cancer	0.00204	0.00224	CcSEcCtD
Flunisolide—Body temperature increased—Etoposide—germ cell cancer	0.00204	0.00224	CcSEcCtD
Flunisolide—SERPINA6—brain—germ cell cancer	0.00204	0.0281	CbGeAlD
Flunisolide—Asthenia—Cisplatin—germ cell cancer	0.00202	0.00222	CcSEcCtD
Flunisolide—NR3C1—telencephalon—germ cell cancer	0.00198	0.0273	CbGeAlD
Flunisolide—Chills—Methotrexate—germ cell cancer	0.00195	0.00214	CcSEcCtD
Flunisolide—Nausea—Ifosfamide—germ cell cancer	0.00194	0.00213	CcSEcCtD
Flunisolide—Diarrhoea—Cisplatin—germ cell cancer	0.00192	0.00211	CcSEcCtD
Flunisolide—Hypersensitivity—Etoposide—germ cell cancer	0.0019	0.00209	CcSEcCtD
Flunisolide—Malnutrition—Methotrexate—germ cell cancer	0.00189	0.00208	CcSEcCtD
Flunisolide—NR3C1—skin of body—germ cell cancer	0.00189	0.0261	CbGeAlD
Flunisolide—NR3C1—decidua—germ cell cancer	0.00187	0.0259	CbGeAlD
Flunisolide—Dysgeusia—Methotrexate—germ cell cancer	0.00185	0.00203	CcSEcCtD
Flunisolide—Asthenia—Etoposide—germ cell cancer	0.00185	0.00203	CcSEcCtD
Flunisolide—Back pain—Methotrexate—germ cell cancer	0.00183	0.00201	CcSEcCtD
Flunisolide—Pruritus—Etoposide—germ cell cancer	0.00182	0.002	CcSEcCtD
Flunisolide—Vomiting—Cisplatin—germ cell cancer	0.00179	0.00196	CcSEcCtD
Flunisolide—Vision blurred—Methotrexate—germ cell cancer	0.00178	0.00196	CcSEcCtD
Flunisolide—Rash—Cisplatin—germ cell cancer	0.00177	0.00195	CcSEcCtD
Flunisolide—Dermatitis—Cisplatin—germ cell cancer	0.00177	0.00195	CcSEcCtD
Flunisolide—Diarrhoea—Etoposide—germ cell cancer	0.00176	0.00194	CcSEcCtD
Flunisolide—Ill-defined disorder—Methotrexate—germ cell cancer	0.00175	0.00193	CcSEcCtD
Flunisolide—Malaise—Methotrexate—germ cell cancer	0.0017	0.00187	CcSEcCtD
Flunisolide—Dizziness—Etoposide—germ cell cancer	0.0017	0.00187	CcSEcCtD
Flunisolide—Vertigo—Methotrexate—germ cell cancer	0.0017	0.00187	CcSEcCtD
Flunisolide—Nausea—Cisplatin—germ cell cancer	0.00167	0.00184	CcSEcCtD
Flunisolide—Cough—Methotrexate—germ cell cancer	0.00165	0.00181	CcSEcCtD
Flunisolide—NR3C1—gonad—germ cell cancer	0.00165	0.0228	CbGeAlD
Flunisolide—NR3C1—uterus—germ cell cancer	0.00164	0.0226	CbGeAlD
Flunisolide—Vomiting—Etoposide—germ cell cancer	0.00164	0.0018	CcSEcCtD
Flunisolide—Rash—Etoposide—germ cell cancer	0.00162	0.00178	CcSEcCtD
Flunisolide—Dermatitis—Etoposide—germ cell cancer	0.00162	0.00178	CcSEcCtD
Flunisolide—Headache—Etoposide—germ cell cancer	0.00161	0.00177	CcSEcCtD
Flunisolide—Chest pain—Methotrexate—germ cell cancer	0.00161	0.00177	CcSEcCtD
Flunisolide—Myalgia—Methotrexate—germ cell cancer	0.00161	0.00177	CcSEcCtD
Flunisolide—NR3C1—pituitary gland—germ cell cancer	0.00161	0.0222	CbGeAlD
Flunisolide—Discomfort—Methotrexate—germ cell cancer	0.00159	0.00175	CcSEcCtD
Flunisolide—NR3C1—medulla oblongata—germ cell cancer	0.00155	0.0214	CbGeAlD
Flunisolide—Infection—Methotrexate—germ cell cancer	0.00153	0.00168	CcSEcCtD
Flunisolide—Nausea—Etoposide—germ cell cancer	0.00153	0.00168	CcSEcCtD
Flunisolide—Hyperhidrosis—Methotrexate—germ cell cancer	0.00149	0.00164	CcSEcCtD
Flunisolide—NR3C1—adrenal gland—germ cell cancer	0.00144	0.0199	CbGeAlD
Flunisolide—NR3C1—midbrain—germ cell cancer	0.00142	0.0196	CbGeAlD
Flunisolide—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.00141	0.00154	CcSEcCtD
Flunisolide—Insomnia—Methotrexate—germ cell cancer	0.0014	0.00153	CcSEcCtD
Flunisolide—NR3C1—bone marrow—germ cell cancer	0.00139	0.0192	CbGeAlD
Flunisolide—NR3C1—spinal cord—germ cell cancer	0.00138	0.0191	CbGeAlD
Flunisolide—Dyspnoea—Methotrexate—germ cell cancer	0.00138	0.00151	CcSEcCtD
Flunisolide—Dyspepsia—Methotrexate—germ cell cancer	0.00136	0.00149	CcSEcCtD
Flunisolide—Decreased appetite—Methotrexate—germ cell cancer	0.00134	0.00147	CcSEcCtD
Flunisolide—NR3C1—female gonad—germ cell cancer	0.00134	0.0185	CbGeAlD
Flunisolide—Fatigue—Methotrexate—germ cell cancer	0.00133	0.00146	CcSEcCtD
Flunisolide—Pain—Methotrexate—germ cell cancer	0.00132	0.00145	CcSEcCtD
Flunisolide—Feeling abnormal—Methotrexate—germ cell cancer	0.00127	0.0014	CcSEcCtD
Flunisolide—Gastrointestinal pain—Methotrexate—germ cell cancer	0.00126	0.00139	CcSEcCtD
Flunisolide—NR3C1—endocrine gland—germ cell cancer	0.00125	0.0172	CbGeAlD
Flunisolide—NR3C1—head—germ cell cancer	0.00123	0.017	CbGeAlD
Flunisolide—Urticaria—Methotrexate—germ cell cancer	0.00123	0.00135	CcSEcCtD
Flunisolide—Body temperature increased—Methotrexate—germ cell cancer	0.00122	0.00134	CcSEcCtD
Flunisolide—Abdominal pain—Methotrexate—germ cell cancer	0.00122	0.00134	CcSEcCtD
Flunisolide—NR3C1—testis—germ cell cancer	0.00119	0.0164	CbGeAlD
Flunisolide—Hypersensitivity—Methotrexate—germ cell cancer	0.00114	0.00125	CcSEcCtD
Flunisolide—Asthenia—Methotrexate—germ cell cancer	0.00111	0.00122	CcSEcCtD
Flunisolide—NR3C1—cerebellum—germ cell cancer	0.0011	0.0152	CbGeAlD
Flunisolide—Pruritus—Methotrexate—germ cell cancer	0.00109	0.0012	CcSEcCtD
Flunisolide—Diarrhoea—Methotrexate—germ cell cancer	0.00106	0.00116	CcSEcCtD
Flunisolide—Dizziness—Methotrexate—germ cell cancer	0.00102	0.00112	CcSEcCtD
Flunisolide—Vomiting—Methotrexate—germ cell cancer	0.000981	0.00108	CcSEcCtD
Flunisolide—Rash—Methotrexate—germ cell cancer	0.000973	0.00107	CcSEcCtD
Flunisolide—Dermatitis—Methotrexate—germ cell cancer	0.000972	0.00107	CcSEcCtD
Flunisolide—Headache—Methotrexate—germ cell cancer	0.000967	0.00106	CcSEcCtD
Flunisolide—CYP3A4—endocrine gland—germ cell cancer	0.000942	0.013	CbGeAlD
Flunisolide—Nausea—Methotrexate—germ cell cancer	0.000916	0.00101	CcSEcCtD
Flunisolide—NR3C1—brain—germ cell cancer	0.000891	0.0123	CbGeAlD
Flunisolide—NR3C1—lymph node—germ cell cancer	0.000861	0.0119	CbGeAlD
